These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 25622855

  • 1. Effects of food intake on pharmacokinetics of mosapride in beagle dogs.
    Chae JW, Song BJ, Baek IH, Yun HY, Ma JY, Kwon KI.
    J Vet Pharmacol Ther; 2015 Oct; 38(5):497-9. PubMed ID: 25622855
    [Abstract] [Full Text] [Related]

  • 2. Determination of influence of food intake after a single oral dose of mosapride in beagle dogs using nonlinear mixed effect modeling.
    Chae JW, Hwang JA, Baek IH, Pradhan S, Song B, Back HM, Yun M, Pai C, Bang JS, Yun HY, Kang W, Kwon KI.
    J Vet Pharmacol Ther; 2015 Dec; 38(6):590-5. PubMed ID: 25955782
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic analysis of mosapride following intravenous and oral administration in beagle dogs.
    Kim MS, Baek IH.
    J Vet Pharmacol Ther; 2020 Sep; 43(5):454-460. PubMed ID: 32304239
    [Abstract] [Full Text] [Related]

  • 4. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of the gastroprokinetic agent mosapride citrate after single oral administration in horses.
    Okamura K, Sasaki N, Fukunaka M, Yamada H, Inokuma H.
    J Vet Med Sci; 2010 Aug; 72(8):1023-6. PubMed ID: 20467210
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in dogs and monkeys.
    Sakashita M, Mizuki Y, Yamaguchi T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Aug; 43(8):864-6. PubMed ID: 8216444
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in rats.
    Sakashita M, Mizuki Y, Hashizume T, Yamaguchi T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Aug; 43(8):859-63. PubMed ID: 8216443
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic and bioavailability studies of 5 mg mosapride tablets in healthy Korean volunteers.
    Kim SH, Park YS, Kim JM, Park HJ, Lee MH, Park HK, Kim YJ, Cho SH, Shaw LM, Kang JS.
    Int J Clin Pharmacol Ther; 2012 Jul; 50(7):524-31. PubMed ID: 22541755
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Absorption, distribution, metabolism and excretion of [carbonyl-14C]mosapride citrate after repeated oral administration in rats.
    Matsumoto S, Tagawa M, Hatoyama T, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct; 43(10):1103-8. PubMed ID: 8267677
    [Abstract] [Full Text] [Related]

  • 15. Effects of mosapride citrate on human plasma levels of motilin, gastrin, somatostatin, and secretin.
    Itoh H, Nagano T, Takeyama M.
    Biol Pharm Bull; 2001 Sep; 24(9):1072-5. PubMed ID: 11558572
    [Abstract] [Full Text] [Related]

  • 16. Development of a novel combination tablet containing trimebutine maleate and mosapride citrate for the treatment of functional dyspepsia.
    Cho KH, Choi YK, Kang JH, Choi HG, Yong CS, Park YJ.
    Int J Pharm; 2010 Nov 15; 400(1-2):145-52. PubMed ID: 20826201
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of metabolic profile of mosapride citrate in rat and identification of two new metabolites: Mosapride N-oxide and morpholine ring-opened mosapride by UPLC-ESI-MS/MS.
    Sun X, Niu L, Li X, Lu X, Li F.
    J Pharm Biomed Anal; 2009 Aug 15; 50(1):27-34. PubMed ID: 19362796
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.